← All companies

ADAG

Adagene Inc.

ADAG Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.63

-0.10 -2.68%

Key statistics

from XBRL data in SEC filings

Market cap

$215M

Revenue (TTM)

$7.67M

Net income (TTM)

-$17.6M

EPS (TTM)

$-0.30

P/E ratio

—

Dividend yield

—

Free cash flow

-$15.7M

Cash

$74.5M

Total assets

$78.3M

Gross margin

—

52-week range

$1.30 – $4.85

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 6, 2026 6-K FORM 6-K Apr 17, 2026 6-K FORM 6-K Apr 2, 2026 6-K FORM 6-K Apr 2, 2026 6-K FORM 6-K Apr 1, 2026 20-F Apr 1, 2026 6-K FORM 6-K Jan 23, 2026 6-K FORM 6-K Nov 13, 2025 6-K Aug 12, 2025 6-K FORM 6-K Jul 15, 2025 6-K FORM 6-K Jul 1, 2025 6-K FORM 6-K May 22, 2025 20-F Mar 24, 2025 6-K FORM 6-K Mar 24, 2025 6-K FORM 6-K Jan 27, 2025 6-K/A FORM 6-K/A Nov 7, 2024 6-K/A FORM 6-K/A Nov 7, 2024 6-K FORM 6-K Nov 7, 2024 6-K FORM 6-K Sep 16, 2024 6-K Jul 25, 2024 6-K FORM 6-K Mar 29, 2024 20-F FORM 20-F Mar 29, 2024 6-K FORM 6-K Mar 29, 2024 6-K FORM 6-K Feb 9, 2024 6-K FORM 6-K Jan 16, 2024 6-K FORM 6-K Nov 3, 2023 6-K FORM 6-K Sep 29, 2023 6-K FORM 6-K Aug 31, 2023 6-K FORM 6-K Jul 7, 2023 6-K FORM 6-K May 4, 2023 6-K FORM 6-K Apr 28, 2023 20-F FORM 20-F Apr 28, 2023 6-K FORM 6-K Apr 18, 2023 6-K FORM 6-K Mar 28, 2023 6-K FORM 6-K Jan 9, 2023 6-K FORM 6-K Dec 16, 2022 6-K FORM 6-K Nov 21, 2022 6-K FORM 6-K Sep 12, 2022 6-K FORM 6-K Aug 31, 2022 6-K FORM 6-K Jun 29, 2022